[ET Net News Agency, 28 November 2023] JW THERAP-B (02126) rose 21.1% to HK$3.27.
It hits an intra-day high of HK$3.27, hitting an 1-month high, and an intra-day low of
HK$2.71. The total shares traded was 3.73 million, with a value of HK$11.23m. The active
buy/sell ratio is 63:37, with net buying turnover of HK$2.9m. MORGAN STANLEY HK SEC
accounts for greatest net responsive buying turnover of HK$447,871, with volume weighted
average price of HK$3.09. HSBC SEC BRO (ASIA) accounts for greatest net responsive selling
turnover of HK$459,418, with volume weighted average price of HK$3.106. The stock has
risen a combined 28.7% over the past 2 consecutive trading days.
Basic Information
=================
---------------------------------
Nominal 3.270 % Chg +21.11%
High 3.270 Low 2.710
Shares Tr 3.73m Turnover 11.23m
10-D SMA 2.664 %H.V 80.495
20-D SMA 2.569 VWAP 3.013
50-D SMA 2.220 RSI14 74.522
---------------------------------
Status: Hitting an 1-month high, active buy/sell ratio is 63:37, with net buying turnover
of HK$2.9m, rising a combined 28.7% over the past 2 consecutive trading days
Performance of stocks in the same sector or of relevance
========================================================
Stock (Code) Price (HK$) Change (%)
---------------------------------------------
JW THERAP-B (02126) 3.27 +21.11
GENSCRIPT BIO (01548) 23.30 +2.42
INNOVENT BIO (01801) 45.55 +0.55
EVEREST MED-B (01952) 21.35 -1.84
WUXI BIO (02269) 45.60 -0.98
WUXI APPTEC (02359) 94.65 +1.83
BEIGENE (06160) 110.50 -0.45
CANSINOBIO (06185) 27.40 +3.40
ZAI LAB (09688) 22.05 -0.23
AKESO (09926) 50.15 +4.81
---------------------------------------------
(ed)